RankAlpha logo
Back to Rankings

HLN

HaleonB
NYSE / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
9
U.S. public peers
Grade Position
In line
vs peer average
HLN vs peer average
62/100
HLN vs. peer average (B vs. C)
Grade spread
A 2 · B 2 · C 2 · D 2 · F 1
Graded peers loaded
Coverage
9 graded
100% of tracked

Peer overview

KVUE is the first available peer comparator.

Kenvue is a direct operating comparator because it is a pure-play consumer-health company with global over-the-counter, oral-care, and skin-health brands. Haleon’s 2025 annual report identifies Kenvue as a participant in its consumer-health sector, although Kenvue’s pending acquisition creates continuity and valuation-comparison limitations.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerKVUEKenvue
HLN
Haleon
KVUE
Kenvue
Grade
B
D
Momentum
32
54
Value
66
50
Sentiment
71
42
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs KVUE

HLN / KVUE
Grade Position
In line
HLN vs. peer average (B vs. C)
62/100
Momentum
32
KVUE
Value
66
HLN
Sentiment
71
HLN

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HLN
1
KVUE
KVUE
D
40/100
+2
2
A
Agilent Technologies Inc Common
A
100/100
-1
3
TEVA
Teva Pharmaceutical Industries Ltd ADR
B
80/100
Even
4
ONC
BeOne Medicines Ltd ADR
C
60/100
+1
5
WAT
Waters Corp Common
C
60/100
+1
KVUE is the first peer returned for this comparison set.